The role of biobanks in realising the One Health approach Time: 24.03.26, 10:00-11:30 via Zoom Register here. One Health aims at sustainably balancing and optimising the health of humans, animals, plants and the environment. This integrated perspective is especially important for tackling emerging zoonotic diseases, antimicrobial resistance, food safety risks, environmental pollution and global health […]
Save the date! The next ECRD will be held on 3 & 4 June 2026 in Prague and will be titled “Rare Diseases in a Changing & Competitive Europe: Shaping policies to address the unmet needs of people living with rare diseases”. The European Conference on Rare Diseases & Orphan Products (ECRD) is the largest patient-led […]
Cancer survivorship at the core of research: How lived experiences can inform research and policy decisions in the Era of the EU Cancer Mission Date/Time: June 3, 2026. H 10.30/11.30 CEST – ONLINE (ZOOM) 🔗 Register here Description Cancer survivorship is rapidly emerging as a central dimension of contemporary oncology, reflecting not only advances […]
Introducing our QUALITY LABELLED biobanks #1 Access • Impact • Discovery We will welcome Laura Valentina Renna (Quality Manager – BioCor) and Ronny Baber (Biobank Manager – LMB) as our guests. Agenda: Laura Valentina Renna, BioCor Biobank, Italy Ronny Baber, Leipzig Medical Biobank, Germany Q&A Register here!
The Institute of Genomics of the University of Tartu and the Estonian Genome Foundation invite you to the 25th International Gene Forum on August 25–26, 2026 at the Estonian National Museum in Tartu, Estonia. The event has brought world-renowned experts to Estonia to discuss the latest advancements in the field since 2000. This interdisciplinary conference with an […]
Cancer is an increasingly urgent public health challenge in many middle-income countries, where health systems face constrained resources. In this context, strengthening cancer research and regulatory frameworks requires not only technical capacity, but also inclusive, participatory approaches that meaningfully engage patients and communities. This webinar brings together experts from selected middle-income countries to explore how […]
The webinar will take place on 14 September 2026, 11:30-12:45 CEST ATTENTION: Registration is open until the end of the business day on 9 September 2026. To attend the live webinar, participants must possess a copy of CEN/TS 17626:2021 for licensing purposes. Summary: The webinar series is held in the context of the EU project […]
PART 2 and 3 Register here! The webinar will be split into two parts and held on the following dates: Part 2: 30 September 2026, 10:15 – 11:30 CEST Part 3: 5 October 2026, 10:15 – 11:30 CEST ATTENTION: To attend the live webinar, participants must possess a copy of CEN/TS 17626:2021 for licensing purposes. Summary: […]
2nd Newsroom of 2026 Introducing our QUALITY LABELLED biobanks #2 Access • Impact • Discovery We will welcome Elisa Cantarelli (Quality Manager – CRB-OSR), Christina Tresoldi (Biobank Manager – CRB-OSR) and Denise Stepper (Quality Manager – ibdw) as our guests. Register here
The Monitoring the Preanalytical Phase in Biobanking: Key Variables and QC Strategies, Graz, Austria 13/10/2026 – 13/10/2026, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The […]
PART 4 Register here! The webinar will take place on 16 October 2026, 10:30-11:45 CEST ATTENTION:To attend the live webinar, participants must possess a copy of CEN/TS 17626:2021 for licensing purposes. Summary: The webinar series is held in the context of the EU project CaBRIOH and co-organised by CaBRIOH project partner Medical University of Graz(BBMRI.at coordinator) […]
Register here! The webinar will take place on 10 November 2026, 10:30-11:30 CET Summary: Cell-free DNA (cfDNA) analysis is an increasingly important component of liquid biopsy, enabling non-invasive biomarker research, disease detection and monitoring. Urine represents an attractive specimen type due to its ease of collection and potential to provide information from both urological and […]